Rocket Pharmaceuticals (RCKT) Accounts Payables (2014 - 2026)
Rocket Pharmaceuticals (RCKT) posted Accounts Payables of $21.5 million for Q1 2026, down 21.07% sequentially from $27.3 million in Q4 2025, and down 33.58% YoY from $32.4 million in Q1 2025.
Rocket Pharmaceuticals (RCKT) Accounts Payables (2014 - 2026) Analysis & Trends
Rocket Pharmaceuticals has reported Accounts Payables for 13 years, with the latest figure at $21.5 million in Q1 2026.
- Quarterly Accounts Payables fell 33.58% year-over-year to $21.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.5 million (down 33.58% YoY) and the FY2025 annual result came in at $27.3 million, down 27.85% from the prior year.
- Accounts Payables slipped to $21.5 million in Q1 2026 per RCKT's latest filing, from $27.3 million in the prior quarter.
- Over five years, Accounts Payables peaked at $45.8 million in Q4 2023 and troughed at $20.0 million in Q1 2022.
- A 5-year average of $31.3 million and a median of $30.6 million in 2023 frame the typical range for Accounts Payables.
- The widest YoY moves for Accounts Payables: up 86.9% in 2022, down 39.61% in 2022.
- Over 5 years, Accounts Payables stood at $36.7 million in 2022, then advanced by 24.9% to $45.8 million in 2023, then slipped by 17.39% to $37.8 million in 2024, then fell by 27.85% to $27.3 million in 2025, then retreated by 21.07% to $21.5 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $21.5 million, $27.3 million, and $28.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Rocket Pharmaceuticals | 380.92 Mn | 380.92 Mn | - | 28.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 28.34 Mn |
| Mar 31, 2026 | 21.54 Mn |
| Dec 31, 2025 | 27.29 Mn |
| Sep 30, 2025 | 28.26 Mn |
| Jun 30, 2025 | 40.51 Mn |
| Mar 31, 2025 | 32.44 Mn |
| Dec 31, 2024 | 37.83 Mn |
| Sep 30, 2024 | 37.13 Mn |
| Jun 30, 2024 | 34.73 Mn |
| Mar 31, 2024 | 30.09 Mn |
| Dec 31, 2023 | 45.79 Mn |
| Sep 30, 2023 | 30.62 Mn |
| Jun 30, 2023 | 31.35 Mn |
| Mar 31, 2023 | 28.61 Mn |
| Dec 31, 2022 | 36.66 Mn |
| Sep 30, 2022 | 27.82 Mn |
| Jun 30, 2022 | 21.84 Mn |
| Mar 31, 2022 | 20.03 Mn |
| Dec 31, 2021 | 19.62 Mn |
| Sep 30, 2021 | 22.01 Mn |